The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Celiac Disease-Global Market Insights and Sales Trends 2024
Synopsis
The global Celiac Disease market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Celiac Disease in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Celiac Disease market. Distension, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diarrhea segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Celiac Disease market, driven by demand from China, the second largest economy with some signs of stabilising, the Celiac Disease market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Celiac Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Celiac Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Celiac Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Celiac Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Celiac Disease covered in this report include Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis and Bristol-Myers Squibb, etc.
The global Celiac Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Global Celiac Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Celiac Disease market, Segment by Type:
Distension
Diarrhea
Anorexia
Others
Global Celiac Disease market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Celiac Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Celiac Disease market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Celiac Disease in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Celiac Disease market. Distension, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diarrhea segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Celiac Disease market, driven by demand from China, the second largest economy with some signs of stabilising, the Celiac Disease market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Celiac Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Celiac Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Celiac Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Celiac Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Celiac Disease covered in this report include Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis and Bristol-Myers Squibb, etc.
The global Celiac Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Global Celiac Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Celiac Disease market, Segment by Type:
Distension
Diarrhea
Anorexia
Others
Global Celiac Disease market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Celiac Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Celiac Disease
1.1 Celiac Disease Market Overview
1.1.1 Celiac Disease Product Scope
1.1.2 Celiac Disease Market Status and Outlook
1.2 Global Celiac Disease Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Celiac Disease Market Size by Region (2018-2029)
1.4 Global Celiac Disease Historic Market Size by Region (2018-2023)
1.5 Global Celiac Disease Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Celiac Disease Market Size (2018-2029)
1.6.1 North America Celiac Disease Market Size (2018-2029)
1.6.2 Europe Celiac Disease Market Size (2018-2029)
1.6.3 Asia-Pacific Celiac Disease Market Size (2018-2029)
1.6.4 Latin America Celiac Disease Market Size (2018-2029)
1.6.5 Middle East & Africa Celiac Disease Market Size (2018-2029)
2 Celiac Disease Market by Type
2.1 Introduction
2.1.1 Distension
2.1.2 Diarrhea
2.1.3 Anorexia
2.1.4 Others
2.2 Global Celiac Disease Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Celiac Disease Historic Market Size by Type (2018-2023)
2.2.2 Global Celiac Disease Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Celiac Disease Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Celiac Disease Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Celiac Disease Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Celiac Disease Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Celiac Disease Revenue Breakdown by Type (2018-2029)
3 Celiac Disease Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Celiac Disease Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Celiac Disease Historic Market Size by Application (2018-2023)
3.2.2 Global Celiac Disease Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Celiac Disease Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Celiac Disease Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Celiac Disease Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Celiac Disease Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Celiac Disease Revenue Breakdown by Application (2018-2029)
4 Celiac Disease Competition Analysis by Players
4.1 Global Celiac Disease Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Celiac Disease as of 2022)
4.3 Date of Key Players Enter into Celiac Disease Market
4.4 Global Top Players Celiac Disease Headquarters and Area Served
4.5 Key Players Celiac Disease Product Solution and Service
4.6 Competitive Status
4.6.1 Celiac Disease Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Celiac Disease Products, Services and Solutions
5.1.4 Roche Celiac Disease Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Celiac Disease Products, Services and Solutions
5.2.4 Merck Celiac Disease Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Celiac Disease Products, Services and Solutions
5.3.4 Johnson & Johnson Celiac Disease Revenue (US$ Million) & (2018-2023)
5.3.5 BiolineRx Recent Developments
5.4 BiolineRx
5.4.1 BiolineRx Profile
5.4.2 BiolineRx Main Business
5.4.3 BiolineRx Celiac Disease Products, Services and Solutions
5.4.4 BiolineRx Celiac Disease Revenue (US$ Million) & (2018-2023)
5.4.5 BiolineRx Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Celiac Disease Products, Services and Solutions
5.5.4 Pfizer Celiac Disease Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Innovate Biopharmaceuticals
5.6.1 Innovate Biopharmaceuticals Profile
5.6.2 Innovate Biopharmaceuticals Main Business
5.6.3 Innovate Biopharmaceuticals Celiac Disease Products, Services and Solutions
5.6.4 Innovate Biopharmaceuticals Celiac Disease Revenue (US$ Million) & (2018-2023)
5.6.5 Innovate Biopharmaceuticals Recent Developments
5.7 ImmusanT
5.7.1 ImmusanT Profile
5.7.2 ImmusanT Main Business
5.7.3 ImmusanT Celiac Disease Products, Services and Solutions
5.7.4 ImmusanT Celiac Disease Revenue (US$ Million) & (2018-2023)
5.7.5 ImmusanT Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Celiac Disease Products, Services and Solutions
5.8.4 Novartis Celiac Disease Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Bristol-Myers Squibb
5.9.1 Bristol-Myers Squibb Profile
5.9.2 Bristol-Myers Squibb Main Business
5.9.3 Bristol-Myers Squibb Celiac Disease Products, Services and Solutions
5.9.4 Bristol-Myers Squibb Celiac Disease Revenue (US$ Million) & (2018-2023)
5.9.5 Bristol-Myers Squibb Recent Developments
5.10 Immunomedics
5.10.1 Immunomedics Profile
5.10.2 Immunomedics Main Business
5.10.3 Immunomedics Celiac Disease Products, Services and Solutions
5.10.4 Immunomedics Celiac Disease Revenue (US$ Million) & (2018-2023)
5.10.5 Immunomedics Recent Developments
6 North America
6.1 North America Celiac Disease Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Celiac Disease Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Celiac Disease Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Celiac Disease Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Celiac Disease Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Celiac Disease Market Dynamics
11.1 Celiac Disease Industry Trends
11.2 Celiac Disease Market Drivers
11.3 Celiac Disease Market Challenges
11.4 Celiac Disease Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
